CDC, FDA Recommend Pausing J&J's COVID Vaccine Over Blood Clot Concerns

CBS4's Lauren Pastrana reports there were six cases of blood clots were among more than 6.8 million doses of the Johnson & Johnson vaccine administered in the United States. Read more: https://cbsloc.al/3a7hup6

Video Transcript

- Our team coverage moves now to more information on how we got here. Six women who received the Johnson and Johnson vaccine developed blood clots within two weeks of getting the shot. One of those women died. Again, more than 6.8 million doses have been given leading up to today's pause.

Here's why federal officials say suspending the shots is the right thing to do. The FDA and CDC recommended a pause in use of the Johnson and Johnson COVID-19 vaccine over concerns of a rare blood clot. But top White House health officials say there won't be a significant impact on vaccination efforts.

JEFF ZIENTS: We have more than enough supply of Pfizer and Moderna vaccines to continue the current pace of about three million shots per day.

- Officials say there have been six reported cases of blood clots out of more than 6.8 million doses delivered. One woman died. All six cases occurred in women between the ages of 18 and 48, and their symptoms developed 6 to 13 days after receiving the vaccination.

JEFF ZIENTS: This is a really rare event, if you look at what we know so far.

- Federal health officials say those who've received the vaccine recently should seek medical attention if they develop any of these symptoms. They also warn using the drug heparin to treat the rare blood clot could be dangerous. The CDC will convene an advisory committee meeting Wednesday to discuss the six cases and next steps.

Meanwhile, Johnson and Johnson released a statement saying, quote there is no clear relationship between these rare events and its vaccine. Top administration health officials say the pause could last anywhere from days to weeks.

And today, FDA officials emphasize that the pause is a recommendation and not a mandate, adding that individual health care providers would not be stopped from administering the Johnson and Johnson vaccine to patients if they determine the benefits outweigh the risks.

Florida Governor, Ron DeSantis, says the state of Florida is following the CDC and FDA'S recommendations. The Johnson and Johnson COVID-19 vaccine is not being given at state run sites for now.